PharmaGap Reports Significant Progress in Development of Liposomal Formulations of Cancer Drug GAP-107B8|
Thursday, May 05, 2011
Initial testing of a liposomal delivery formulation for PharmaGap's lead cancer drug GAP-107B8 for therapeutic use in humans.
Olink Bioscience Introduces its New Plasma Biomarker Discovery Service
Monday, April 25, 2011
Using PLA® immunoassay platform, up to 74 potential cancer biomarkers are analyzed with high sensitivity in precious biobanked plasma samples, in no more than 2 µl of sample.
DiaMedica's Type 2 Diabetes Antibody Shown to Increase Glucose Infusion Rate by 291%
Thursday, April 21, 2011
DiaMedica announces positive and important activity with DM-204, its lead monoclonal antibody.
New Column for Superior Separation of Structurally Related Isomers
Tuesday, April 12, 2011
The Acclaim® C30 from Dionex is a new reversed-phase HPLC column that is suited to a broad range of separations.
MetaMap® Tox - A Novel Technology for Early Safety Enablement in Pharmaceutical Development will be Validated by Industry Consortium
Friday, April 08, 2011
Cambridge Healthtech Associates and Metanomics Health GmbH announce a collaborative technology evaluation.
Glycated Albumin Presented as a Novel Biomarker for Diabetes Monitoring
Friday, April 08, 2011
Glycated albumin is the cornerstone of Epinex's flagship product - the G1A™ Rapid Diabetes Monitoring Index Test.
Breakthrough Research Method for the Detection and Absolute Quantification of Metabolites using GC-MS/MS-MRM Technology
Monday, March 28, 2011
Thermo Fisher Scientific Inc. announces an innovative new method for the detection and absolute quantification of metabolites based on the Thermo Scientific TSQ Quantum XLS in multiple reaction mode (MRM).
Thermo Scientific Unveils Research Method for the Detection and Absolute Quantification of Metabolites
Saturday, March 26, 2011
Using GC-MS/MS-MRM technology, scientists are able to conduct both discovery phase analysis and selective identification and quantification analysis with a single instrument.
Lpath Granted Another Key U.S. Patent Related to iSONEP and ASONEP Drug Programs
Thursday, March 10, 2011
New U.S. patent adds to four others received over last six months.